Ex-Suzuki team manager Davide Brivio has revealed the Japanese marque reached out to him through Facebook to enquire if Valentino Rossi would be interested in joining for its MotoGP comeback.
The T.J.Maxx clearance sale is on and there’s lots of loungewear that you’ll want to snag while it’s marked down. If that’s you, then take advantage of the T.J.Maxx clearance sale where comfy, cozy pieces are up to 75 percent off.
This season's Super Bowl hasn't been played, but it's not too early to think about next season.
ABC Technologies Holdings Inc. ("ABC Technologies" or the "Company") announced today that it has filed with the securities regulatory authorities in each of the provinces and territories in Canada, and obtained a receipt for, a preliminary long-form prospectus (the "Preliminary Prospectus") for a proposed initial public offering of common shares (the "Offering"). The Offering contemplates an offering of common shares of ABC Technologies by ABC Group Canada LP, which is directly and indirectly owned by an investment fund managed by Cerberus Capital Management, L.P. The number of common shares to be sold and the price per common share have not yet been determined.
Twitter said, with the new product, academic researchers will be able to tap into all the tools released to date on the new API platform, which will enable them to listen to and analyze public conversations. The data will not, however, include tweets from accounts suspended for violations of Twitter rules, which means academics will be unable to use the API to study tweets by former U.S. President Donald Trump, company executives told reporters on Monday.
Shares of CarParts.com (NASDAQ: PRTS) were revving today after some electric vehicle pixie dust landed on the stock today. The online car parts seller said it just launched a marketplace for electric vehicles, hybrids, and plug-in hybrids. Investors have been going gaga for anything related to the electric vehicle industry so it's not a surprise to see shares of the e-commerce stock charging higher on the news.
Six-time IndyCar race-winner James Hinchcliffe will become a full-time Andretti Autosport-Honda driver in 2021, as Genesys steps up its commitment to the popular Canadian racer.
The World Health Organisation says health workers in high-risk settings and very old people should be vaccinated against the coronavirus first.
For years, Sears (OTCMKTS: SHLDQ) has been a mall and shopping center mainstay, drawing in customers and serving as a key tenant and revenue source for commercial landlords. 2020 was a year when many big-name department stores filed for bankruptcy. Quite the contrary -- Sears is now down to just 74 stores, compared to nearly 1,000 locations as of three years ago.
BRO earnings call for the period ending December 31, 2020.
United Natural Foods, Inc. (NYSE: UNFI) ("UNFI") today announced that it launched a repricing transaction of its senior secured term loan facility that targets a reduction in the Applicable Margin (as defined in the term loan agreement) of 50 to 75 basis points.
In a sector that had precious few outperformers, marijuana stock GrowGeneration (NASDAQ: GRWG) was a standout in 2020, rising by nearly 900%. In this video segment from Motley Fool Live recorded on Dec. 22, 2020, healthcare and cannabis bureau chief Corinne Cardina and veteran Fool contributor Eric Volkman discussed whether GrowGeneration can continue to be a hot investment this year, too. Corinne Cardina: The first stock I want to talk about is actually the best pot stock of 2020.
SUFFERN, N.Y., Jan. 26, 2021 (GLOBE NEWSWIRE) -- WATS3D, an AI-powered diagnostic platform developed by CDx Diagnostics to identify precancerous and cancerous cells in the esophagus, is now considered a medically necessary service by BlueCross BlueShield of South Carolina. In accordance with accepted standards of medical practice based on credible scientific evidence and gastrointestinal society recommendations, South Carolina’s largest privately-owned and operated health insurance carrier will now cover WATS3D testing for over 1.2 million members. WATS3D overcomes the limitations associated with traditional upper endoscopy screening and surveillance methods through the use of a unique combination of superior sampling, advanced 3D imaging, and advanced Artificial Intelligence analysis to reliably detect Barrett’s esophagus (BE) and esophageal dysplasia. In large multicenter clinical trials, WATS3D was found to significantly increase the detection rate of both BE and esophageal dysplasia, demonstrating the far-reaching implications of the WATS3D Artificial Intelligence-powered diagnostic platform for diagnosing and preventing esophageal cancer, one of the fastest growing and most fatal cancers in the US. “CDx Diagnostics, Inc. is excited to receive the medically necessary designation for WATS3D from BlueCross BlueShield of South Carolina,” said Bill Huffnagle, CEO of CDx Diagnostics. “South Carolina joins Massachusetts and Hawaii as states where insurers are recognizing the impact on patient outcomes and the importance of making WATS3D testing more widely available. Physicians in those states now have advanced technology and screening they can use in the fight against cancer while their patients have peace of mind in knowing the testing is covered through their insurance plans.” CDx has completed the five major pillars of evidence-based medicine for WATS3D, including Analytic Validity, Clinical Validity, Clinical Utility, Cost Effectiveness and Recommendations by Major Medical Societies. The technology has earned recognition from the American Society for Gastrointestinal Endoscopy (ASGE), the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) and the American Foregut Society (AFS). In 2019, the ASGE included WATS3D in its Standards of Practice Committee’s guideline for the screening and surveillance of BE. In 2020, the technology was deemed a safe and effective adjunct to forceps biopsies in the evaluation of BE, low-grade dysplasia, and high-grade dysplasia by SAGES and its Technology and Value Assessment Committee (TAVAC). About CDx DiagnosticsCDx Diagnostics’ mission of Empowering Physicians With Innovative Technology To Prevent Esophageal Cancer, One Patient at a Time is accomplished by a proprietary diagnostic platform that synthesizes computer imaging, artificial intelligence, molecular biology and three-dimensional cytopathology to detect precancerous change earlier and more reliably than prior methods. CDx tests require only a few minutes of practice time, are highly cost effective, widely reimbursed, and address a recognized critical gap in the current diagnostic standard of care that results in thousands of otherwise unnecessary cancer deaths each year. Routine clinical use of CDx testing has already detected thousands of cancers that would otherwise have been missed in time for effective endoscopic treatment and application of the CDx Diagnostics platform to prevent cancers of the bile duct, stomach, and IBD affected colon is currently in progress. CDx Diagnostics is a Galen Partners portfolio company. To learn more, visit http://www.cdxdiagnostics.com. Contact: Donnie TurlingtonPhone: 336-991-7711
General Mills, Inc. (NYSE: GIS) announced today that Chairman and Chief Executive Officer Jeff Harmening, Chief Marketing Officer Ivan Pollard, and Chief Financial Officer Kofi Bruce will be featured speakers at the Consumer Analyst Group of New York Conference, to be held virtually on Tuesday, February 16, 2021. A webcast of the pre-recorded presentation is scheduled to begin at 7:00 a.m. CT and a replay of the event will be available at www.generalmills.com/investors.
MINNEAPOLIS, Jan. 26, 2021 (GLOBE NEWSWIRE) -- Jamf (NASDAQ: JAMF), the standard in Apple Enterprise Management, today announced that IDC, a global provider of market intelligence, has named Jamf a leader in its inaugural “Worldwide Unified Endpoint Management Software for Apple Devices 2021 Vendor Assessment.” The vendor assessment report states, “The Adoption of Mac usage in the enterprise (1,000+ employees) is growing by many measures. In the United States, average penetration of macOS devices is around 23%, compared with 17% in 2019.” The report continues, “Macs, of course, are not the entire story around Apple devices in the enterprise. According to IDC's 2020 enterprise survey, iPhones account for 49% of the smartphone installed base among U.S. enterprises, and iPads make up the majority of tablets used in business. The proliferation of Apple devices — macOS devices, as well as iPhones, iPads, and Apple TV — in business is causing many organizations to rethink their approach to overall endpoint provisioning, management, and security.” Jamf’s Apple Enterprise Management platform is the only solution of scale that automates the entire lifecycle of Apple in the enterprise, including device deployment, management and security, while optimizing the legendary Apple user experience and eliminating the need for IT personnel to touch the device. According to the report, Jamf’s leadership ranking was attributed to the following strengths: The company's singular focus on Apple and thus its ability to consistently provide same-day compatibility and feature support for all new operating systems, including macOS, iOS, iPad OS, tvOS and watchOS.A strong ecosystem of integrations with industry-specific solutions and Jamf offerings that create unique workflows for iPads and iPhones within industries like healthcare, retail, transportation and education.The company’s strength in Mac management features, coupled with Mac-specific identity and security products. “Since 2002, Jamf has been exclusively focused on helping organizations succeed with Apple, and today, the demand for Apple has never been stronger. We believe that end users deserve to use technology they want at work, and therefore, security and IT teams need a technology partner that focuses on the unique needs of this ecosystem,” said Dean Hager, CEO, Jamf. “We are excited to be named a leader in IDC’s Apple Enterprise Management report, and more importantly, are honored to help our more than 47,000 customers succeed with Apple every day.” An excerpt of the IDC MarketScape Unified Endpoint Management Software for Apple Devices 2021 Vendor Assessment can be downloaded here. About IDC MarketScapeIDC MarketScape vendor assessment model is designed to provide an overview of the competitive fitness of ICT (information and communications technology) suppliers in a given market. The research methodology utilizes a rigorous scoring methodology based on both qualitative and quantitative criteria that results in a single graphical illustration of each vendor’s position within a given market. IDC MarketScape provides a clear framework in which the product and service offerings, capabilities and strategies, and current and future market success factors of IT and telecommunications vendors can be meaningfully compared. The framework also provides technology buyers with a 360-degree assessment of the strengths and weaknesses of current and prospective vendors. About JamfJamf, the standard in Apple Enterprise Management, extends the legendary Apple experience people love to businesses, schools and government organizations through its software and the world’s largest online community of IT admins focused exclusively on Apple, Jamf Nation. To learn more, visit: www.jamf.com. Media Contact:Aleena Kaleemmedia@jamf.com Investor Contact:Jennifer Gaumondir@jamf.com
The Hanger Foundation today announced the creation of the Hanger Foundation Diversity Scholarship as part of its commitment to diversity and inclusion in the orthotics and prosthetics (O&P) profession. To help address nationwide systemic racism, interrupt bias, and ultimately create a more inclusive profession, Hanger, Inc. (NYSE: HNGR) committed to take tangible actions. One of the five areas of focus was attracting more diverse candidates to O&P graduate programs.
The global patient registry software market value was USD 1.10 Billion in 2019, which is expected to reach USD 2.96 Billion by 2027, and register a CAGR of 13.9% during the forecast period.Vancouver, British Columbia, Jan. 26, 2021 (GLOBE NEWSWIRE) -- The global patient registry software market is forecast to reach a value of USD 2.96 Billion by 2027, at a rapid and steady CAGR of 13.9%, according to results of a recent study and analysis by Emergen Research. Increasing prevalence of chronic diseases globally is expected to drive demand and adoption of more advanced and efficient software and approaches to maintain patient records among others, and this is expected to drive growth of the global patient registry software market over the forecast period. In addition, increasing government initiatives related to offering value-based care in developed and developing countries is further projected to result in accelerated growth of the global patient registry software market growth over the forecast period. Shift towards patient-powered research networks in the healthcare sector is also expected to drive growth of the global patient registry software market during the forecast period. Claim Your FREE Sample Copy with Table of content@ https://www.emergenresearch.com/request-sample-form/465 However, lack or low availability of skilled or trained professionals to develop and maintain patient health records (to reduce healthcare costs) in the healthcare sector is expected to impact growth of the patient registry software market to a certain extent during the forecast period. Key Highlights of Report The on-premises segment is expected to register a stable CAGR of 13.9% over the forecast period. On-premise patient registry software offers benefits such as robust data transfer efficiency, reliable data recovery, and improved data and information protection and safety, which is expected to result in increasing preference and adoption at healthcare facilities. Using patient registry software, healthcare workers can cooperate internationally for purposes of legally sharing data with the objective of enabling health advancements, and especially in conditions wherein need arises when a patient is suffering from a rare disease. Owing to these advantages and enhanced features and functionalities, demand and deployment of this software has been increasing, and is expected to continue to drive market growth.Due to the growing introduction of patient registry software in the pharma companies to monitor accurate patient data for new medicine development, revenue from the pharmaceutical company segment is projected to increase substantially during the forecast period.Due to increase in prevalence of chronic diseases among the geriatric population in countries in Asia Pacific, the market in this region is expected to register significant growth during the forecast period.Key market participants include IQVIA Holdings, Inc., ImageTrend, Inc., McKesson Corporation, Optum, Inc., International Business Machines Corporation, Syneos Health Inc., Premier, Inc., Phytel, Inc., Telligen, Inc., and Dacima Software Inc.In May 2020, NaviHealth, Inc. was acquired by Optum, Inc. Through this deal, Optum will incorporate NaviHealth's post-acute treatment model and data-driven expertise with the current population-based health services and clinical resources to deliver personalized, value-based care for patients with complicated health issues. Check Our Prices@ https://www.emergenresearch.com/select-license/465Emergen Research has segmented the global Patient Registry Software market on the basis of delivery, database, registry type, function, software type, end-use, and region. Delivery Outlook (Revenue, USD Billion; 2020–2027) Cloud-basedOn-premises Database Outlook (Revenue, USD Billion; 2020–2027) Public DatabaseCommercial Database Registry Type Outlook (Revenue, USD Billion; 2020–2027) Product RegistriesHealth Service RegistriesDisease Registries Function Outlook (Revenue, USD Billion; 2020–2027) Point-Of-CarePatient Care Management Population Health Management Product Outcome EvaluationHealth Information ExchangeResearch & Clinical Studies Software Type Outlook (Revenue, USD Billion; 2020–2027) IntegratedStandalone End-use Outlook (Revenue, USD Billion; 2020–2027) Government & Third-Party AdministratorsPharmaceutical CompaniesHospitals Research CentersOthers Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends: http://www.emergenresearch.com/industry-report/patient-registry-software-market Regional Outlook (Revenue, USD Billion; 2020–2027) North America U.S.CanadaMexico Europe GermanyU.K.FranceBENELUXRest of Europe Asia Pacific China JapanSouth KoreaIndiaRest of APAC Latin America BrazilRest of LATAM Middle East & Africa Saudi ArabiaUAERest of MEA Take a Look at our Related Reports: AI-Enabled Medical Imaging Solutions Market By Product (Software, Hardware), By Workflow (Image Acquisition, Image Analysis, Reporting, and Communication), By Therapeutic Application (General Imaging, Specialty Imaging), By Deployment Mode, By Modality, and By Region, Forecasts to 2027 Patient Registry Software Market By Delivery, By Database, By Registry Type, By Function, By Software Type (Integrated, Standalone), By End-use (Government & Third-Party Administrators, Pharmaceutical Companies, Hospitals, Research Centers, Others), and By Region, Forecast to 2027 Operating Room Management Solutions Market By Solution Type (Data management and communication solutions, Operating room supply management solutions, Anesthesia information management solutions, Operating room scheduling solutions, Performance management solutions), By Mode of Deployment (Ob-premises, Cloud-based), By End-Use (Hospitals, Ambulatory surgical centers), and By Region About Emergen Research Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors. Contact Us: Eric Lee Corporate Sales Specialist Emergen Research | Web: www.emergenresearch.com Direct Line: +1 (604) 757-9756 E-mail: email@example.com Facebook | LinkedIn | Twitter | Blogs Read Full Press Release@ http://www.emergenresearch.com/press-release/global-patient-registry-software-market
YPrime has launched their fifth-generation electronic clinical outcome assessment (eCOA) platform featuring and improved user experience.
Bringing it to Africa, only 10 percent of the West African startups that cumulatively raised $1 million had at least one female co-founder in the past decade. In a male-dominated space, programs geared toward supporting female entrepreneurs have emerged to close the gap on all fronts. FirstCheck Africa, a female-focused angel fund that launched yesterday, is hoping to address this challenge.
B&H is excited to announce Sony’s new flagship mirrorless the camera: the Alpha a1. Packed with advanced photo and video features, the a1 Camera is a full-frame hybrid camera aimed at professionals whose work demands the highest quality imagery and performance from a single camera. No longer will creators have to sacrifice photo or video features when choosing a mirrorless camera.